 Shawn St Peter
Concepts (954)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 103 | 2023 | 207 | 22.920 |
Why?
| | Appendicitis | 61 | 2023 | 115 | 18.780 |
Why?
| | Appendectomy | 51 | 2023 | 100 | 14.880 |
Why?
| | Humans | 437 | 2024 | 6896 | 13.430 |
Why?
| | Retrospective Studies | 243 | 2024 | 1296 | 12.960 |
Why?
| | Male | 263 | 2024 | 3337 | 11.180 |
Why?
| | Funnel Chest | 27 | 2023 | 55 | 11.110 |
Why?
| | Child | 277 | 2024 | 3364 | 10.870 |
Why?
| | Female | 262 | 2024 | 3525 | 10.530 |
Why?
| | Postoperative Complications | 68 | 2024 | 184 | 9.000 |
Why?
| | Treatment Outcome | 121 | 2024 | 622 | 8.260 |
Why?
| | Child, Preschool | 138 | 2024 | 1569 | 7.550 |
Why?
| | Adolescent | 154 | 2024 | 2197 | 7.270 |
Why?
| | Infant | 136 | 2024 | 1446 | 6.940 |
Why?
| | Wounds, Nonpenetrating | 32 | 2024 | 56 | 6.920 |
Why?
| | Pain, Postoperative | 20 | 2022 | 35 | 6.860 |
Why?
| | Gastroesophageal Reflux | 19 | 2021 | 41 | 6.590 |
Why?
| | Fundoplication | 22 | 2021 | 35 | 6.540 |
Why?
| | Prospective Studies | 82 | 2024 | 525 | 6.210 |
Why?
| | Abdominal Abscess | 15 | 2021 | 25 | 5.760 |
Why?
| | Anti-Bacterial Agents | 28 | 2024 | 243 | 5.690 |
Why?
| | Surgical Wound Infection | 22 | 2024 | 44 | 5.220 |
Why?
| | Tomography, X-Ray Computed | 42 | 2024 | 117 | 5.100 |
Why?
| | Analgesia, Patient-Controlled | 12 | 2019 | 17 | 4.780 |
Why?
| | Infant, Newborn | 95 | 2024 | 816 | 4.640 |
Why?
| | Follow-Up Studies | 56 | 2023 | 304 | 4.410 |
Why?
| | Length of Stay | 55 | 2023 | 233 | 4.340 |
Why?
| | Empyema, Pleural | 7 | 2024 | 13 | 3.860 |
Why?
| | Liver | 24 | 2024 | 126 | 3.860 |
Why?
| | Thoracoscopy | 18 | 2022 | 27 | 3.810 |
Why?
| | Spleen | 18 | 2024 | 30 | 3.780 |
Why?
| | Postoperative Care | 13 | 2020 | 30 | 3.780 |
Why?
| | Foreign Bodies | 9 | 2021 | 23 | 3.660 |
Why?
| | Drainage | 17 | 2024 | 36 | 3.520 |
Why?
| | Minimally Invasive Surgical Procedures | 20 | 2023 | 38 | 3.350 |
Why?
| | Gastrostomy | 15 | 2023 | 63 | 3.310 |
Why?
| | Cholecystectomy, Laparoscopic | 11 | 2021 | 25 | 3.290 |
Why?
| | Gastroschisis | 12 | 2024 | 23 | 3.120 |
Why?
| | Enteral Nutrition | 15 | 2023 | 63 | 3.090 |
Why?
| | Pyloric Stenosis, Hypertrophic | 9 | 2023 | 21 | 3.070 |
Why?
| | Hernia, Inguinal | 14 | 2022 | 28 | 3.010 |
Why?
| | Esophagus | 12 | 2020 | 29 | 3.010 |
Why?
| | Pneumothorax | 12 | 2023 | 30 | 2.940 |
Why?
| | Esophageal Atresia | 15 | 2022 | 32 | 2.910 |
Why?
| | Randomized Controlled Trials as Topic | 12 | 2020 | 55 | 2.780 |
Why?
| | Tracheoesophageal Fistula | 12 | 2022 | 27 | 2.770 |
Why?
| | Pediatrics | 19 | 2020 | 186 | 2.760 |
Why?
| | Hernias, Diaphragmatic, Congenital | 10 | 2016 | 18 | 2.710 |
Why?
| | Abdominal Injuries | 16 | 2024 | 26 | 2.710 |
Why?
| | Practice Patterns, Physicians' | 12 | 2021 | 85 | 2.470 |
Why?
| | Hospitals, Pediatric | 18 | 2021 | 187 | 2.450 |
Why?
| | Thoracic Surgery, Video-Assisted | 8 | 2024 | 20 | 2.430 |
Why?
| | Digestive System Surgical Procedures | 12 | 2019 | 38 | 2.370 |
Why?
| | Cryptorchidism | 5 | 2024 | 16 | 2.300 |
Why?
| | Wounds and Injuries | 6 | 2022 | 38 | 2.290 |
Why?
| | Fibrinolytic Agents | 5 | 2024 | 8 | 2.280 |
Why?
| | Time Factors | 32 | 2024 | 250 | 2.260 |
Why?
| | Intussusception | 7 | 2020 | 12 | 2.250 |
Why?
| | Analgesia, Epidural | 4 | 2019 | 9 | 2.230 |
Why?
| | Recurrence | 21 | 2023 | 110 | 2.180 |
Why?
| | Clinical Protocols | 10 | 2018 | 29 | 2.150 |
Why?
| | Ceftriaxone | 7 | 2015 | 13 | 2.150 |
Why?
| | Pyloric Stenosis | 6 | 2016 | 10 | 2.130 |
Why?
| | Cryosurgery | 3 | 2022 | 11 | 2.120 |
Why?
| | Hirschsprung Disease | 8 | 2022 | 52 | 2.100 |
Why?
| | Tissue Plasminogen Activator | 4 | 2020 | 5 | 1.970 |
Why?
| | Herniorrhaphy | 11 | 2022 | 23 | 1.960 |
Why?
| | Sutures | 5 | 2021 | 11 | 1.890 |
Why?
| | Reoperation | 20 | 2023 | 59 | 1.850 |
Why?
| | Anesthesia, Epidural | 4 | 2015 | 4 | 1.830 |
Why?
| | United States | 37 | 2024 | 669 | 1.760 |
Why?
| | Surgical Mesh | 6 | 2012 | 8 | 1.740 |
Why?
| | Patient Satisfaction | 11 | 2023 | 38 | 1.730 |
Why?
| | Metronidazole | 6 | 2015 | 16 | 1.670 |
Why?
| | Ultrasonography | 11 | 2024 | 46 | 1.640 |
Why?
| | Crohn Disease | 4 | 2014 | 25 | 1.630 |
Why?
| | Colitis, Ulcerative | 3 | 2023 | 13 | 1.630 |
Why?
| | Laparotomy | 12 | 2021 | 21 | 1.620 |
Why?
| | Guideline Adherence | 2 | 2024 | 36 | 1.610 |
Why?
| | Algorithms | 12 | 2023 | 105 | 1.600 |
Why?
| | Suture Techniques | 6 | 2020 | 12 | 1.600 |
Why?
| | Catheterization, Central Venous | 6 | 2016 | 18 | 1.590 |
Why?
| | Abdominal Pain | 5 | 2019 | 71 | 1.550 |
Why?
| | Intestinal Obstruction | 8 | 2019 | 19 | 1.540 |
Why?
| | Hernia, Hiatal | 5 | 2015 | 7 | 1.520 |
Why?
| | Trauma Centers | 18 | 2024 | 37 | 1.520 |
Why?
| | Suction | 5 | 2015 | 6 | 1.500 |
Why?
| | General Surgery | 8 | 2016 | 19 | 1.480 |
Why?
| | Hernia, Umbilical | 7 | 2022 | 14 | 1.460 |
Why?
| | Pylorus | 7 | 2015 | 12 | 1.440 |
Why?
| | Cicatrix | 3 | 2016 | 5 | 1.440 |
Why?
| | Operative Time | 13 | 2022 | 27 | 1.440 |
Why?
| | Hernia, Diaphragmatic | 8 | 2012 | 13 | 1.430 |
Why?
| | Esophagoscopy | 5 | 2020 | 11 | 1.410 |
Why?
| | Umbilicus | 5 | 2018 | 8 | 1.370 |
Why?
| | Peritoneal Lavage | 3 | 2015 | 5 | 1.360 |
Why?
| | Thrombolytic Therapy | 3 | 2024 | 8 | 1.330 |
Why?
| | Costal Cartilage | 2 | 2021 | 4 | 1.320 |
Why?
| | Severity of Illness Index | 7 | 2018 | 149 | 1.310 |
Why?
| | Patient Discharge | 9 | 2023 | 57 | 1.300 |
Why?
| | Urinary Retention | 4 | 2018 | 5 | 1.280 |
Why?
| | Enterocolitis, Necrotizing | 11 | 2021 | 67 | 1.260 |
Why?
| | Risk Factors | 24 | 2024 | 487 | 1.260 |
Why?
| | Ileum | 3 | 2014 | 15 | 1.240 |
Why?
| | Specialties, Surgical | 6 | 2016 | 14 | 1.240 |
Why?
| | Unnecessary Procedures | 4 | 2023 | 13 | 1.230 |
Why?
| | Circumcision, Male | 2 | 2018 | 3 | 1.230 |
Why?
| | Kidney | 5 | 2013 | 94 | 1.220 |
Why?
| | Evidence-Based Medicine | 8 | 2014 | 48 | 1.220 |
Why?
| | Intestinal Volvulus | 5 | 2019 | 11 | 1.220 |
Why?
| | Adult | 25 | 2022 | 1181 | 1.210 |
Why?
| | Abscess | 5 | 2014 | 10 | 1.200 |
Why?
| | Gallbladder Diseases | 4 | 2016 | 12 | 1.200 |
Why?
| | Ribs | 3 | 2021 | 6 | 1.180 |
Why?
| | Radiography, Thoracic | 5 | 2017 | 10 | 1.160 |
Why?
| | Enterocolitis | 3 | 2022 | 34 | 1.140 |
Why?
| | Quality Improvement | 6 | 2018 | 60 | 1.120 |
Why?
| | Obesity | 4 | 2022 | 125 | 1.110 |
Why?
| | Bed Rest | 5 | 2013 | 8 | 1.110 |
Why?
| | Intestinal Perforation | 7 | 2021 | 11 | 1.110 |
Why?
| | Preoperative Care | 12 | 2023 | 26 | 1.100 |
Why?
| | Databases, Factual | 8 | 2021 | 108 | 1.100 |
Why?
| | Ileal Diseases | 3 | 2018 | 7 | 1.100 |
Why?
| | Incidence | 28 | 2024 | 133 | 1.080 |
Why?
| | Cholelithiasis | 3 | 2015 | 7 | 1.070 |
Why?
| | Fluoroscopy | 7 | 2020 | 19 | 1.060 |
Why?
| | Radiography | 8 | 2018 | 37 | 1.060 |
Why?
| | Appendix | 4 | 2018 | 11 | 1.050 |
Why?
| | Esophageal Achalasia | 2 | 2016 | 3 | 1.050 |
Why?
| | Pain Measurement | 7 | 2019 | 45 | 1.040 |
Why?
| | Surveys and Questionnaires | 13 | 2022 | 274 | 1.020 |
Why?
| | Blood Transfusion | 6 | 2017 | 13 | 1.000 |
Why?
| | Biliary Dyskinesia | 4 | 2019 | 9 | 1.000 |
Why?
| | Thoracotomy | 5 | 2023 | 18 | 1.000 |
Why?
| | Injury Severity Score | 17 | 2024 | 52 | 0.980 |
Why?
| | Colitis | 2 | 2023 | 12 | 0.980 |
Why?
| | Electric Power Supplies | 2 | 2021 | 4 | 0.960 |
Why?
| | Chest Tubes | 8 | 2023 | 21 | 0.940 |
Why?
| | Esophageal Perforation | 2 | 2017 | 4 | 0.940 |
Why?
| | Combined Modality Therapy | 11 | 2018 | 46 | 0.940 |
Why?
| | Orthopedic Procedures | 5 | 2018 | 14 | 0.930 |
Why?
| | Urinary Catheterization | 4 | 2018 | 4 | 0.920 |
Why?
| | Liver Transplantation | 6 | 2004 | 47 | 0.920 |
Why?
| | Biomedical Research | 4 | 2018 | 27 | 0.920 |
Why?
| | Ambulatory Surgical Procedures | 5 | 2018 | 13 | 0.920 |
Why?
| | Thoracic Surgical Procedures | 5 | 2011 | 9 | 0.910 |
Why?
| | Testis | 4 | 2024 | 26 | 0.910 |
Why?
| | Burns | 5 | 2023 | 12 | 0.910 |
Why?
| | Histamine H2 Antagonists | 3 | 2017 | 7 | 0.890 |
Why?
| | Age Factors | 12 | 2021 | 210 | 0.880 |
Why?
| | Antibiotic Prophylaxis | 9 | 2024 | 30 | 0.880 |
Why?
| | Catheterization | 4 | 2016 | 29 | 0.870 |
Why?
| | Stomach | 3 | 2018 | 11 | 0.860 |
Why?
| | Cecum | 2 | 2014 | 4 | 0.860 |
Why?
| | Risk Assessment | 13 | 2023 | 137 | 0.860 |
Why?
| | Enema | 6 | 2020 | 17 | 0.850 |
Why?
| | Young Adult | 14 | 2023 | 647 | 0.850 |
Why?
| | Lung Diseases | 2 | 2022 | 23 | 0.850 |
Why?
| | Child Abuse | 3 | 2022 | 46 | 0.850 |
Why?
| | Referral and Consultation | 2 | 2024 | 32 | 0.840 |
Why?
| | Clinical Trials as Topic | 4 | 2018 | 45 | 0.840 |
Why?
| | Intercostal Nerves | 2 | 2022 | 6 | 0.840 |
Why?
| | Intestine, Small | 6 | 2014 | 15 | 0.830 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 17 | 0.830 |
Why?
| | Esophagoplasty | 3 | 2020 | 4 | 0.820 |
Why?
| | Splenectomy | 5 | 2017 | 8 | 0.810 |
Why?
| | Pancreas | 4 | 2017 | 8 | 0.810 |
Why?
| | Intubation, Gastrointestinal | 5 | 2018 | 20 | 0.790 |
Why?
| | Device Removal | 5 | 2023 | 14 | 0.790 |
Why?
| | Equipment Contamination | 2 | 2021 | 6 | 0.780 |
Why?
| | Pancreatitis | 4 | 2022 | 8 | 0.780 |
Why?
| | Perioperative Care | 2 | 2018 | 11 | 0.780 |
Why?
| | Ovarian Neoplasms | 3 | 2023 | 136 | 0.770 |
Why?
| | Prognosis | 15 | 2019 | 211 | 0.760 |
Why?
| | Protective Clothing | 1 | 2021 | 2 | 0.760 |
Why?
| | Fomites | 1 | 2021 | 2 | 0.760 |
Why?
| | Electrical Equipment and Supplies | 1 | 2021 | 2 | 0.760 |
Why?
| | Surgical Attire | 1 | 2021 | 2 | 0.760 |
Why?
| | Critical Pathways | 3 | 2018 | 8 | 0.750 |
Why?
| | Birth Weight | 7 | 2018 | 28 | 0.750 |
Why?
| | Pneumoperitoneum, Artificial | 2 | 2011 | 4 | 0.750 |
Why?
| | Numismatics | 1 | 2020 | 3 | 0.750 |
Why?
| | Surgical Procedures, Operative | 6 | 2024 | 15 | 0.750 |
Why?
| | Organ Preservation | 5 | 2003 | 6 | 0.740 |
Why?
| | Respiratory Insufficiency | 3 | 2019 | 13 | 0.730 |
Why?
| | Heart Defects, Congenital | 4 | 2018 | 81 | 0.730 |
Why?
| | Intestinal Atresia | 4 | 2023 | 16 | 0.730 |
Why?
| | Intraoperative Care | 3 | 2018 | 6 | 0.720 |
Why?
| | Acute Disease | 8 | 2023 | 79 | 0.720 |
Why?
| | Cohort Studies | 14 | 2022 | 289 | 0.720 |
Why?
| | Biocompatible Materials | 2 | 2012 | 2 | 0.710 |
Why?
| | Diagnostic Imaging | 2 | 2017 | 16 | 0.710 |
Why?
| | Research Design | 3 | 2020 | 63 | 0.700 |
Why?
| | Gallstones | 3 | 2022 | 4 | 0.700 |
Why?
| | Orchiopexy | 3 | 2022 | 7 | 0.690 |
Why?
| | Sensitivity and Specificity | 10 | 2018 | 150 | 0.680 |
Why?
| | Medical Errors | 1 | 2019 | 6 | 0.670 |
Why?
| | Tissue Adhesions | 2 | 2017 | 9 | 0.670 |
Why?
| | Pericardium | 2 | 2011 | 5 | 0.670 |
Why?
| | Thoracostomy | 4 | 2021 | 7 | 0.660 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 42 | 0.650 |
Why?
| | Drug Therapy, Combination | 7 | 2018 | 35 | 0.650 |
Why?
| | Sodium Chloride | 2 | 2016 | 3 | 0.640 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 20 | 0.640 |
Why?
| | Internship and Residency | 4 | 2023 | 39 | 0.640 |
Why?
| | Fluid Therapy | 3 | 2023 | 17 | 0.640 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 8 | 0.640 |
Why?
| | Pleural Effusion | 3 | 2016 | 5 | 0.640 |
Why?
| | Phimosis | 1 | 2018 | 1 | 0.630 |
Why?
| | Practice Guidelines as Topic | 7 | 2024 | 108 | 0.630 |
Why?
| | Neuromuscular Diseases | 1 | 2018 | 7 | 0.630 |
Why?
| | Colonic Diseases | 3 | 2014 | 6 | 0.630 |
Why?
| | Malnutrition | 1 | 2018 | 8 | 0.620 |
Why?
| | Tissue Adhesives | 2 | 2017 | 3 | 0.620 |
Why?
| | Gestational Age | 12 | 2019 | 62 | 0.620 |
Why?
| | Bronchoscopy | 5 | 2016 | 7 | 0.610 |
Why?
| | Drug Administration Schedule | 7 | 2018 | 35 | 0.610 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2016 | 16 | 0.610 |
Why?
| | Sample Size | 1 | 2017 | 3 | 0.610 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 36 | 0.610 |
Why?
| | Lung Neoplasms | 4 | 2022 | 23 | 0.610 |
Why?
| | Colectomy | 2 | 2023 | 14 | 0.600 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.600 |
Why?
| | Administration, Oral | 9 | 2018 | 58 | 0.600 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2019 | 18 | 0.600 |
Why?
| | Diagnosis, Differential | 10 | 2021 | 77 | 0.600 |
Why?
| | Anastomosis, Surgical | 7 | 2023 | 21 | 0.590 |
Why?
| | Ranitidine | 2 | 2015 | 5 | 0.590 |
Why?
| | Esophageal pH Monitoring | 3 | 2012 | 4 | 0.580 |
Why?
| | Disease Management | 4 | 2021 | 34 | 0.580 |
Why?
| | Dissection | 2 | 2014 | 3 | 0.570 |
Why?
| | Therapeutic Irrigation | 4 | 2022 | 10 | 0.570 |
Why?
| | Pulmonary Emphysema | 2 | 2019 | 2 | 0.570 |
Why?
| | Cartilage Diseases | 1 | 2016 | 3 | 0.560 |
Why?
| | Joint Diseases | 1 | 2016 | 4 | 0.560 |
Why?
| | Quality of Life | 3 | 2021 | 140 | 0.560 |
Why?
| | Health Resources | 2 | 2014 | 17 | 0.560 |
Why?
| | Fever | 2 | 2014 | 26 | 0.560 |
Why?
| | Pilonidal Sinus | 2 | 2019 | 3 | 0.550 |
Why?
| | Proctocolectomy, Restorative | 2 | 2020 | 3 | 0.550 |
Why?
| | Patient Readmission | 7 | 2020 | 68 | 0.550 |
Why?
| | Predictive Value of Tests | 8 | 2023 | 99 | 0.550 |
Why?
| | Refusal to Participate | 1 | 2016 | 1 | 0.540 |
Why?
| | Radiography, Interventional | 1 | 2016 | 1 | 0.540 |
Why?
| | Parents | 4 | 2023 | 157 | 0.540 |
Why?
| | High-Frequency Ventilation | 2 | 2016 | 3 | 0.540 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 130 | 0.530 |
Why?
| | Pancreatectomy | 2 | 2013 | 4 | 0.530 |
Why?
| | Rectum | 5 | 2019 | 27 | 0.530 |
Why?
| | Nervous System Diseases | 2 | 2014 | 13 | 0.530 |
Why?
| | Hospital Costs | 3 | 2016 | 29 | 0.530 |
Why?
| | Body Mass Index | 7 | 2016 | 157 | 0.520 |
Why?
| | Duodenal Obstruction | 5 | 2023 | 14 | 0.520 |
Why?
| | Overweight | 3 | 2014 | 49 | 0.520 |
Why?
| | Cost-Benefit Analysis | 6 | 2016 | 25 | 0.510 |
Why?
| | Meckel Diverticulum | 3 | 2018 | 7 | 0.510 |
Why?
| | Pain | 5 | 2023 | 57 | 0.510 |
Why?
| | Wounds, Gunshot | 4 | 2022 | 12 | 0.510 |
Why?
| | Patient Selection | 4 | 2021 | 40 | 0.510 |
Why?
| | Personal Satisfaction | 4 | 2023 | 10 | 0.500 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2015 | 1 | 0.500 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.500 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.500 |
Why?
| | Dilatation | 1 | 2015 | 3 | 0.500 |
Why?
| | Diagnostic Self Evaluation | 2 | 2021 | 2 | 0.500 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 21 | 0.500 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 18 | 0.490 |
Why?
| | Ileostomy | 2 | 2011 | 3 | 0.490 |
Why?
| | Apnea | 2 | 2012 | 5 | 0.480 |
Why?
| | Hospitalization | 8 | 2023 | 210 | 0.480 |
Why?
| | Treatment Failure | 7 | 2019 | 16 | 0.480 |
Why?
| | Neutropenia | 2 | 2011 | 12 | 0.480 |
Why?
| | Vascular Access Devices | 1 | 2014 | 1 | 0.470 |
Why?
| | Needles | 1 | 2014 | 3 | 0.470 |
Why?
| | Equipment Failure | 1 | 2014 | 10 | 0.470 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 5 | 0.460 |
Why?
| | Respiratory Aspiration | 1 | 2013 | 2 | 0.460 |
Why?
| | Anticoagulants | 3 | 2024 | 20 | 0.460 |
Why?
| | Postoperative Period | 7 | 2018 | 18 | 0.450 |
Why?
| | Pain Threshold | 1 | 2013 | 3 | 0.450 |
Why?
| | Diaphragm | 2 | 2010 | 6 | 0.440 |
Why?
| | Debridement | 2 | 2012 | 4 | 0.440 |
Why?
| | Postoperative Nausea and Vomiting | 2 | 2013 | 5 | 0.440 |
Why?
| | Contrast Media | 3 | 2014 | 23 | 0.440 |
Why?
| | Venous Thrombosis | 1 | 2013 | 2 | 0.440 |
Why?
| | Elective Surgical Procedures | 4 | 2018 | 14 | 0.430 |
Why?
| | Lung | 5 | 2022 | 65 | 0.430 |
Why?
| | Abdominal Wall | 3 | 2020 | 4 | 0.430 |
Why?
| | Tietze's Syndrome | 1 | 2012 | 1 | 0.430 |
Why?
| | Therapeutic Equipoise | 1 | 2012 | 1 | 0.430 |
Why?
| | Cartilage | 1 | 2012 | 2 | 0.430 |
Why?
| | Biopsy | 6 | 2019 | 60 | 0.430 |
Why?
| | Decision Making | 1 | 2013 | 23 | 0.430 |
Why?
| | Genital Diseases, Male | 1 | 2012 | 1 | 0.420 |
Why?
| | Comorbidity | 6 | 2017 | 56 | 0.420 |
Why?
| | Splenic Neoplasms | 1 | 2012 | 1 | 0.420 |
Why?
| | Infant, Premature, Diseases | 4 | 2021 | 22 | 0.420 |
Why?
| | Hemangioma | 1 | 2012 | 3 | 0.420 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2012 | 3 | 0.420 |
Why?
| | Silver Sulfadiazine | 1 | 2012 | 3 | 0.420 |
Why?
| | Collagenases | 1 | 2012 | 3 | 0.420 |
Why?
| | Ovarian Cysts | 1 | 2012 | 2 | 0.420 |
Why?
| | Middle Aged | 7 | 2016 | 608 | 0.410 |
Why?
| | Societies, Medical | 5 | 2017 | 51 | 0.410 |
Why?
| | Firearms | 2 | 2022 | 7 | 0.410 |
Why?
| | Reproducibility of Results | 9 | 2022 | 199 | 0.410 |
Why?
| | Venous Thromboembolism | 2 | 2024 | 13 | 0.410 |
Why?
| | Cystadenoma, Mucinous | 1 | 2012 | 1 | 0.410 |
Why?
| | Heart Injuries | 1 | 2011 | 3 | 0.400 |
Why?
| | Insufflation | 1 | 2011 | 2 | 0.400 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2011 | 1 | 0.400 |
Why?
| | Single-Blind Method | 4 | 2018 | 12 | 0.400 |
Why?
| | Monitoring, Physiologic | 1 | 2012 | 23 | 0.400 |
Why?
| | Adrenalectomy | 1 | 2011 | 1 | 0.390 |
Why?
| | Insurance Coverage | 2 | 2022 | 21 | 0.390 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.380 |
Why?
| | Sports Equipment | 1 | 2011 | 1 | 0.380 |
Why?
| | Embolization, Therapeutic | 3 | 2024 | 12 | 0.380 |
Why?
| | Accidents, Home | 1 | 2011 | 5 | 0.380 |
Why?
| | Health Care Surveys | 5 | 2018 | 33 | 0.380 |
Why?
| | Hemorrhage | 3 | 2022 | 19 | 0.370 |
Why?
| | Pulmonary Blastoma | 3 | 2022 | 5 | 0.370 |
Why?
| | Iatrogenic Disease | 2 | 2010 | 7 | 0.370 |
Why?
| | Ossification, Heterotopic | 1 | 2010 | 1 | 0.370 |
Why?
| | Thymoma | 1 | 2010 | 1 | 0.370 |
Why?
| | Thymus Neoplasms | 1 | 2010 | 2 | 0.370 |
Why?
| | Abdomen | 3 | 2022 | 12 | 0.370 |
Why?
| | Jejunal Diseases | 1 | 2010 | 3 | 0.370 |
Why?
| | Periodicity | 1 | 2010 | 2 | 0.370 |
Why?
| | Duodenal Diseases | 1 | 2010 | 6 | 0.370 |
Why?
| | Decompression, Surgical | 1 | 2010 | 5 | 0.360 |
Why?
| | Nutritional Support | 1 | 2010 | 5 | 0.360 |
Why?
| | Xiphoid Bone | 1 | 2010 | 4 | 0.360 |
Why?
| | Fecal Incontinence | 3 | 2020 | 23 | 0.360 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2010 | 24 | 0.360 |
Why?
| | Laparoscopes | 1 | 2010 | 1 | 0.360 |
Why?
| | Cholecystectomy | 4 | 2022 | 9 | 0.360 |
Why?
| | Digestive System Abnormalities | 2 | 2009 | 6 | 0.360 |
Why?
| | Histamine H1 Antagonists | 1 | 2010 | 5 | 0.360 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 5 | 0.350 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 4 | 0.350 |
Why?
| | Bezoars | 1 | 2009 | 2 | 0.350 |
Why?
| | Empyema | 2 | 2009 | 3 | 0.350 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2009 | 5 | 0.350 |
Why?
| | Intestinal Mucosa | 3 | 2019 | 41 | 0.340 |
Why?
| | Ileocecal Valve | 1 | 2009 | 2 | 0.340 |
Why?
| | Wounds, Penetrating | 2 | 2023 | 5 | 0.340 |
Why?
| | Case-Control Studies | 6 | 2022 | 215 | 0.340 |
Why?
| | Infant, Premature | 7 | 2021 | 85 | 0.340 |
Why?
| | Colon | 3 | 2015 | 14 | 0.340 |
Why?
| | Esophageal Stenosis | 3 | 2022 | 7 | 0.330 |
Why?
| | Thrombin | 1 | 2009 | 1 | 0.330 |
Why?
| | Wounds, Stab | 1 | 2009 | 1 | 0.330 |
Why?
| | Tibial Arteries | 1 | 2009 | 1 | 0.330 |
Why?
| | Aneurysm, False | 1 | 2009 | 2 | 0.330 |
Why?
| | Ultrasonography, Interventional | 1 | 2009 | 5 | 0.330 |
Why?
| | Hemostatics | 1 | 2009 | 3 | 0.330 |
Why?
| | Longitudinal Studies | 4 | 2021 | 119 | 0.330 |
Why?
| | Cholecystitis | 2 | 2008 | 6 | 0.330 |
Why?
| | Survival Rate | 6 | 2021 | 83 | 0.330 |
Why?
| | Alkalosis | 1 | 2008 | 1 | 0.330 |
Why?
| | Hypokalemia | 1 | 2008 | 1 | 0.330 |
Why?
| | Delivery, Obstetric | 2 | 2024 | 5 | 0.320 |
Why?
| | Regression Analysis | 4 | 2019 | 52 | 0.320 |
Why?
| | Braces | 2 | 2019 | 8 | 0.320 |
Why?
| | Pectus Carinatum | 2 | 2019 | 8 | 0.320 |
Why?
| | Anesthetics | 2 | 2021 | 4 | 0.320 |
Why?
| | Missouri | 5 | 2018 | 81 | 0.320 |
Why?
| | Workload | 1 | 2008 | 9 | 0.320 |
Why?
| | Gentamicins | 1 | 2008 | 5 | 0.320 |
Why?
| | Medical Staff, Hospital | 1 | 2008 | 4 | 0.320 |
Why?
| | Aged | 5 | 2015 | 378 | 0.310 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 13 | 0.310 |
Why?
| | Patient Care Team | 1 | 2008 | 19 | 0.310 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2020 | 41 | 0.310 |
Why?
| | Anesthesia, Intravenous | 1 | 2008 | 1 | 0.310 |
Why?
| | Splenic Rupture | 1 | 2008 | 2 | 0.310 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 66 | 0.310 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2018 | 15 | 0.310 |
Why?
| | Milk, Human | 3 | 2019 | 23 | 0.310 |
Why?
| | Internal Fixators | 1 | 2007 | 3 | 0.300 |
Why?
| | Electrolytes | 3 | 2021 | 11 | 0.300 |
Why?
| | Hospital Charges | 3 | 2016 | 11 | 0.300 |
Why?
| | Pandemics | 6 | 2023 | 82 | 0.300 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.290 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.290 |
Why?
| | Hernia | 2 | 2018 | 3 | 0.290 |
Why?
| | Logistic Models | 4 | 2019 | 84 | 0.290 |
Why?
| | Pneumonectomy | 3 | 2021 | 4 | 0.290 |
Why?
| | Gastrointestinal Diseases | 2 | 2017 | 45 | 0.280 |
Why?
| | Ovariectomy | 2 | 2023 | 3 | 0.280 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2006 | 1 | 0.280 |
Why?
| | Vascular Surgical Procedures | 1 | 2006 | 3 | 0.280 |
Why?
| | Hypertension, Renovascular | 1 | 2006 | 4 | 0.280 |
Why?
| | Blood Vessels | 1 | 2006 | 5 | 0.280 |
Why?
| | Airway Obstruction | 3 | 2013 | 20 | 0.280 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 52 | 0.280 |
Why?
| | Eating | 3 | 2021 | 31 | 0.280 |
Why?
| | Shock, Septic | 2 | 2021 | 4 | 0.280 |
Why?
| | Radiation Dosage | 3 | 2014 | 5 | 0.270 |
Why?
| | Ostomy | 2 | 2018 | 5 | 0.270 |
Why?
| | Rectal Prolapse | 2 | 2020 | 9 | 0.270 |
Why?
| | Forecasting | 2 | 2020 | 22 | 0.270 |
Why?
| | Multiple Trauma | 3 | 2013 | 10 | 0.270 |
Why?
| | Infant, Newborn, Diseases | 3 | 2018 | 30 | 0.260 |
Why?
| | Superior Mesenteric Artery Syndrome | 2 | 2020 | 4 | 0.260 |
Why?
| | Intention to Treat Analysis | 2 | 2018 | 7 | 0.260 |
Why?
| | Pleura | 1 | 2005 | 1 | 0.260 |
Why?
| | Thoracic Injuries | 2 | 2021 | 7 | 0.260 |
Why?
| | Spherocytosis, Hereditary | 2 | 2015 | 3 | 0.260 |
Why?
| | Feasibility Studies | 4 | 2021 | 58 | 0.260 |
Why?
| | Guidelines as Topic | 2 | 2018 | 11 | 0.250 |
Why?
| | Duodenum | 2 | 2020 | 21 | 0.250 |
Why?
| | Urinary Diversion | 1 | 2005 | 1 | 0.250 |
Why?
| | Anemia, Sickle Cell | 2 | 2015 | 17 | 0.250 |
Why?
| | Anal Canal | 2 | 2022 | 25 | 0.250 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2011 | 19 | 0.250 |
Why?
| | Gastric Bypass | 1 | 2005 | 8 | 0.250 |
Why?
| | Pilot Projects | 3 | 2019 | 120 | 0.250 |
Why?
| | Morbidity | 2 | 2016 | 11 | 0.250 |
Why?
| | Surgical Stomas | 2 | 2018 | 3 | 0.250 |
Why?
| | Recovery of Function | 3 | 2019 | 17 | 0.240 |
Why?
| | Gastrointestinal Tract | 2 | 2018 | 7 | 0.240 |
Why?
| | Colorectal Surgery | 2 | 2014 | 8 | 0.240 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2004 | 3 | 0.240 |
Why?
| | Prevalence | 4 | 2018 | 146 | 0.240 |
Why?
| | Chest Pain | 2 | 2021 | 3 | 0.240 |
Why?
| | ROC Curve | 2 | 2016 | 22 | 0.240 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2004 | 4 | 0.240 |
Why?
| | Pain Management | 2 | 2015 | 27 | 0.240 |
Why?
| | Evidence-Based Practice | 5 | 2023 | 17 | 0.240 |
Why?
| | Esthetics | 3 | 2013 | 7 | 0.230 |
Why?
| | Intraoperative Complications | 2 | 2015 | 4 | 0.230 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2003 | 1 | 0.230 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2003 | 1 | 0.230 |
Why?
| | Plastics | 2 | 2014 | 2 | 0.230 |
Why?
| | Pregnancy | 5 | 2022 | 216 | 0.230 |
Why?
| | Vomiting | 3 | 2020 | 23 | 0.230 |
Why?
| | Pneumonia | 3 | 2017 | 32 | 0.230 |
Why?
| | Liver Neoplasms | 1 | 2003 | 15 | 0.230 |
Why?
| | Skin Transplantation | 2 | 2014 | 4 | 0.230 |
Why?
| | Splenic Diseases | 2 | 2017 | 2 | 0.230 |
Why?
| | Liver Circulation | 1 | 2003 | 2 | 0.220 |
Why?
| | Rupture, Spontaneous | 3 | 2016 | 7 | 0.220 |
Why?
| | Animals | 5 | 2021 | 729 | 0.220 |
Why?
| | Gastrointestinal Agents | 1 | 2023 | 4 | 0.220 |
Why?
| | Registries | 3 | 2019 | 92 | 0.220 |
Why?
| | Infliximab | 1 | 2023 | 7 | 0.220 |
Why?
| | Steroids | 1 | 2023 | 16 | 0.220 |
Why?
| | Reperfusion | 2 | 2002 | 2 | 0.220 |
Why?
| | Age Distribution | 4 | 2013 | 31 | 0.220 |
Why?
| | Lethargy | 2 | 2013 | 2 | 0.220 |
Why?
| | Injections, Intravenous | 2 | 2015 | 15 | 0.220 |
Why?
| | Clinical Competence | 2 | 2015 | 29 | 0.220 |
Why?
| | Chlorides | 2 | 2016 | 4 | 0.220 |
Why?
| | Bicarbonates | 2 | 2016 | 8 | 0.220 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 20 | 0.220 |
Why?
| | Prenatal Diagnosis | 5 | 2021 | 14 | 0.220 |
Why?
| | Testicular Hydrocele | 1 | 2022 | 1 | 0.210 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2022 | 6 | 0.210 |
Why?
| | Propensity Score | 2 | 2021 | 8 | 0.210 |
Why?
| | Respiratory System Abnormalities | 2 | 2019 | 3 | 0.210 |
Why?
| | Endoscopy | 2 | 2012 | 14 | 0.210 |
Why?
| | Equipment Design | 3 | 2014 | 14 | 0.210 |
Why?
| | Tissue and Organ Procurement | 1 | 2002 | 17 | 0.210 |
Why?
| | Stomach Neoplasms | 1 | 2022 | 7 | 0.210 |
Why?
| | Anthropometry | 2 | 2012 | 15 | 0.210 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 15 | 0.210 |
Why?
| | Testicular Neoplasms | 1 | 2022 | 2 | 0.200 |
Why?
| | Surgeons | 3 | 2016 | 7 | 0.200 |
Why?
| | Craniocerebral Trauma | 2 | 2014 | 18 | 0.200 |
Why?
| | Masks | 1 | 2021 | 6 | 0.200 |
Why?
| | Community-Acquired Infections | 2 | 2011 | 10 | 0.200 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 23 | 0.200 |
Why?
| | Statistics, Nonparametric | 1 | 2021 | 17 | 0.190 |
Why?
| | Pleural Diseases | 3 | 2011 | 5 | 0.190 |
Why?
| | Phyllodes Tumor | 1 | 2021 | 1 | 0.190 |
Why?
| | Fibroadenoma | 1 | 2021 | 1 | 0.190 |
Why?
| | Motivation | 1 | 2021 | 16 | 0.190 |
Why?
| | Patient Compliance | 2 | 2019 | 55 | 0.190 |
Why?
| | Mastectomy, Segmental | 1 | 2021 | 4 | 0.190 |
Why?
| | Hypothermia | 1 | 2021 | 2 | 0.190 |
Why?
| | Watchful Waiting | 1 | 2021 | 7 | 0.190 |
Why?
| | Sepsis | 2 | 2019 | 23 | 0.190 |
Why?
| | Anesthesia, General | 1 | 2021 | 1 | 0.190 |
Why?
| | Breast Neoplasms | 1 | 2021 | 38 | 0.190 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2018 | 2 | 0.190 |
Why?
| | Kidney Transplantation | 1 | 2002 | 115 | 0.190 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 5 | 0.190 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 7 | 0.190 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 16 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 94 | 0.190 |
Why?
| | Eosinophilia | 2 | 2019 | 29 | 0.190 |
Why?
| | Bacterial Infections | 1 | 2021 | 27 | 0.180 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 19 | 0.180 |
Why?
| | Survival Analysis | 2 | 2018 | 50 | 0.180 |
Why?
| | Ligaments | 1 | 2020 | 4 | 0.180 |
Why?
| | Heart Ventricles | 2 | 2018 | 49 | 0.180 |
Why?
| | Echocardiography | 1 | 2020 | 81 | 0.180 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 1 | 0.180 |
Why?
| | Constipation | 1 | 2020 | 17 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2020 | 2 | 0.180 |
Why?
| | Skin | 1 | 2020 | 15 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2020 | 35 | 0.180 |
Why?
| | Pressure | 3 | 2019 | 9 | 0.180 |
Why?
| | Probability | 3 | 2008 | 15 | 0.170 |
Why?
| | Thoracentesis | 1 | 2019 | 1 | 0.170 |
Why?
| | Gallbladder | 1 | 2019 | 3 | 0.170 |
Why?
| | Short Bowel Syndrome | 1 | 2019 | 4 | 0.170 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 4 | 0.170 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 17 | 0.170 |
Why?
| | Conversion to Open Surgery | 2 | 2019 | 2 | 0.170 |
Why?
| | Self Report | 1 | 2019 | 42 | 0.170 |
Why?
| | Sex Factors | 3 | 2014 | 68 | 0.170 |
Why?
| | Meconium | 2 | 2009 | 3 | 0.170 |
Why?
| | Infusions, Intravenous | 3 | 2021 | 26 | 0.170 |
Why?
| | Pancreatic Pseudocyst | 2 | 2009 | 2 | 0.170 |
Why?
| | Multicenter Studies as Topic | 2 | 2016 | 19 | 0.160 |
Why?
| | Thoracoplasty | 1 | 2018 | 1 | 0.160 |
Why?
| | Pain Perception | 1 | 2018 | 2 | 0.160 |
Why?
| | Anorexia | 1 | 2018 | 2 | 0.160 |
Why?
| | Surgical Instruments | 2 | 2010 | 5 | 0.160 |
Why?
| | Jejunum | 1 | 2018 | 3 | 0.160 |
Why?
| | Urinary Catheters | 1 | 2018 | 2 | 0.160 |
Why?
| | Pancreatic Ducts | 1 | 2018 | 1 | 0.160 |
Why?
| | Attitude to Health | 1 | 2018 | 26 | 0.160 |
Why?
| | Syndrome | 2 | 2016 | 34 | 0.160 |
Why?
| | Analgesics | 1 | 2018 | 5 | 0.160 |
Why?
| | Catheters, Indwelling | 1 | 2018 | 31 | 0.160 |
Why?
| | Narcotics | 1 | 2018 | 5 | 0.160 |
Why?
| | Postoperative Hemorrhage | 1 | 2018 | 1 | 0.160 |
Why?
| | Prostheses and Implants | 2 | 2011 | 7 | 0.160 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.160 |
Why?
| | Organs at Risk | 1 | 2018 | 3 | 0.160 |
Why?
| | Checklist | 1 | 2018 | 4 | 0.160 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 16 | 0.160 |
Why?
| | Fertility Preservation | 1 | 2018 | 7 | 0.150 |
Why?
| | Reference Standards | 1 | 2018 | 15 | 0.150 |
Why?
| | Counseling | 1 | 2018 | 28 | 0.150 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2018 | 8 | 0.150 |
Why?
| | Acetaminophen | 1 | 2018 | 18 | 0.150 |
Why?
| | Cost of Illness | 2 | 2008 | 19 | 0.150 |
Why?
| | Blood Gas Analysis | 2 | 2011 | 6 | 0.150 |
Why?
| | Magnets | 1 | 2017 | 3 | 0.150 |
Why?
| | Complementary Therapies | 1 | 2017 | 3 | 0.150 |
Why?
| | Carbon Dioxide | 2 | 2021 | 14 | 0.150 |
Why?
| | Gastroenterology | 1 | 2017 | 10 | 0.150 |
Why?
| | Ileitis | 1 | 2017 | 3 | 0.150 |
Why?
| | Body Weight | 2 | 2019 | 52 | 0.150 |
Why?
| | Emergency Medical Services | 1 | 2017 | 14 | 0.150 |
Why?
| | Clostridium Infections | 1 | 2017 | 7 | 0.150 |
Why?
| | Trachea | 3 | 2017 | 7 | 0.150 |
Why?
| | Hypotension | 1 | 2017 | 5 | 0.140 |
Why?
| | Decision Support Techniques | 2 | 2015 | 6 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2016 | 11 | 0.140 |
Why?
| | Peritoneal Diseases | 1 | 2016 | 2 | 0.140 |
Why?
| | Program Development | 1 | 2016 | 12 | 0.140 |
Why?
| | Shock, Traumatic | 1 | 2016 | 2 | 0.140 |
Why?
| | Health Status Indicators | 1 | 2016 | 8 | 0.140 |
Why?
| | Vasoconstrictor Agents | 1 | 2016 | 1 | 0.140 |
Why?
| | Infant Formula | 2 | 2013 | 15 | 0.140 |
Why?
| | Weight Loss | 2 | 2008 | 39 | 0.140 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 336 | 0.140 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.140 |
Why?
| | Vocal Cord Paralysis | 2 | 2017 | 3 | 0.140 |
Why?
| | Models, Organizational | 1 | 2016 | 7 | 0.140 |
Why?
| | False Negative Reactions | 2 | 2017 | 9 | 0.140 |
Why?
| | Surgical Flaps | 2 | 2019 | 6 | 0.140 |
Why?
| | Global Health | 1 | 2016 | 15 | 0.140 |
Why?
| | Medical Records | 1 | 2016 | 14 | 0.140 |
Why?
| | Volunteers | 1 | 2016 | 2 | 0.140 |
Why?
| | Perception | 1 | 2016 | 6 | 0.140 |
Why?
| | Comprehension | 1 | 2016 | 3 | 0.140 |
Why?
| | Child Health Services | 1 | 2016 | 24 | 0.140 |
Why?
| | Potassium | 1 | 2016 | 9 | 0.130 |
Why?
| | Resuscitation | 1 | 2016 | 6 | 0.130 |
Why?
| | Heparin | 2 | 2013 | 6 | 0.130 |
Why?
| | Granuloma, Plasma Cell | 1 | 2015 | 2 | 0.130 |
Why?
| | Hospitals | 3 | 2022 | 36 | 0.130 |
Why?
| | Arizona | 3 | 2023 | 8 | 0.130 |
Why?
| | Arkansas | 3 | 2023 | 8 | 0.130 |
Why?
| | Oklahoma | 3 | 2023 | 10 | 0.130 |
Why?
| | Texas | 3 | 2023 | 20 | 0.130 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 42 | 0.130 |
Why?
| | Gastric Mucosa | 1 | 2015 | 14 | 0.130 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 3 | 0.130 |
Why?
| | Odds Ratio | 2 | 2012 | 51 | 0.130 |
Why?
| | Hydromorphone | 1 | 2015 | 1 | 0.130 |
Why?
| | Foreign-Body Reaction | 2 | 2007 | 3 | 0.130 |
Why?
| | Anastomotic Leak | 3 | 2023 | 8 | 0.130 |
Why?
| | Midazolam | 1 | 2015 | 12 | 0.130 |
Why?
| | Fentanyl | 1 | 2015 | 2 | 0.130 |
Why?
| | Sarcoma, Ewing | 1 | 2015 | 7 | 0.130 |
Why?
| | Cathartics | 1 | 2015 | 4 | 0.130 |
Why?
| | Canada | 2 | 2012 | 31 | 0.130 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2015 | 1 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2015 | 19 | 0.130 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.130 |
Why?
| | Catheters | 1 | 2015 | 4 | 0.130 |
Why?
| | Ankyrins | 1 | 2014 | 1 | 0.120 |
Why?
| | Gastroplasty | 1 | 2014 | 1 | 0.120 |
Why?
| | Rectal Diseases | 1 | 2014 | 3 | 0.120 |
Why?
| | Acute Chest Syndrome | 1 | 2014 | 2 | 0.120 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 15 | 0.120 |
Why?
| | Anemia, Hemolytic, Congenital | 1 | 2014 | 3 | 0.120 |
Why?
| | Benchmarking | 1 | 2014 | 11 | 0.120 |
Why?
| | Consensus | 3 | 2020 | 35 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 55 | 0.120 |
Why?
| | Advisory Committees | 1 | 2014 | 9 | 0.120 |
Why?
| | Apgar Score | 3 | 2019 | 6 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 17 | 0.120 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 7 | 0.120 |
Why?
| | Electric Impedance | 2 | 2012 | 3 | 0.120 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2014 | 2 | 0.120 |
Why?
| | Pupil | 1 | 2014 | 3 | 0.120 |
Why?
| | Reflex, Pupillary | 1 | 2014 | 3 | 0.120 |
Why?
| | Histological Techniques | 1 | 2014 | 1 | 0.120 |
Why?
| | Heart | 1 | 2014 | 14 | 0.120 |
Why?
| | Swine | 3 | 2003 | 6 | 0.120 |
Why?
| | Rotation | 2 | 2020 | 5 | 0.120 |
Why?
| | Wound Healing | 2 | 2012 | 6 | 0.120 |
Why?
| | Residence Characteristics | 1 | 2014 | 42 | 0.120 |
Why?
| | Burns, Electric | 1 | 2014 | 1 | 0.120 |
Why?
| | Burns, Chemical | 1 | 2014 | 2 | 0.120 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 2 | 0.120 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 3 | 0.120 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2012 | 5 | 0.120 |
Why?
| | Blood Loss, Surgical | 2 | 2012 | 5 | 0.120 |
Why?
| | Seizures | 1 | 2014 | 25 | 0.120 |
Why?
| | Hemoglobins | 3 | 2022 | 27 | 0.120 |
Why?
| | Tissue Donors | 3 | 2002 | 30 | 0.120 |
Why?
| | Solutions | 1 | 2013 | 3 | 0.110 |
Why?
| | Patients | 1 | 2013 | 2 | 0.110 |
Why?
| | Hematuria | 1 | 2013 | 6 | 0.110 |
Why?
| | Urinalysis | 1 | 2013 | 4 | 0.110 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2020 | 4 | 0.110 |
Why?
| | Respiratory Sounds | 1 | 2013 | 6 | 0.110 |
Why?
| | Nephrectomy | 1 | 2013 | 14 | 0.110 |
Why?
| | Cough | 1 | 2013 | 7 | 0.110 |
Why?
| | Appointments and Schedules | 1 | 2013 | 12 | 0.110 |
Why?
| | Time | 1 | 2013 | 6 | 0.110 |
Why?
| | Oxycodone | 1 | 2013 | 4 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 11 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2013 | 13 | 0.110 |
Why?
| | Interviews as Topic | 1 | 2013 | 20 | 0.110 |
Why?
| | Remission Induction | 1 | 2013 | 24 | 0.110 |
Why?
| | Quality Assurance, Health Care | 1 | 2013 | 7 | 0.110 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.110 |
Why?
| | Risk | 1 | 2013 | 41 | 0.110 |
Why?
| | Publishing | 1 | 2013 | 8 | 0.110 |
Why?
| | Authorship | 1 | 2013 | 3 | 0.110 |
Why?
| | Walking | 1 | 2013 | 34 | 0.110 |
Why?
| | Food | 1 | 2013 | 17 | 0.110 |
Why?
| | Venous Cutdown | 1 | 2013 | 1 | 0.110 |
Why?
| | Jugular Veins | 1 | 2013 | 3 | 0.110 |
Why?
| | Diet | 1 | 2013 | 52 | 0.110 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 85 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 17 | 0.110 |
Why?
| | Enoxaparin | 1 | 2013 | 3 | 0.110 |
Why?
| | Ileus | 2 | 2009 | 3 | 0.110 |
Why?
| | Ethics, Research | 1 | 2012 | 3 | 0.110 |
Why?
| | Organ Specificity | 2 | 2011 | 23 | 0.110 |
Why?
| | Muscle, Smooth | 1 | 2012 | 2 | 0.110 |
Why?
| | Body Size | 1 | 2012 | 7 | 0.110 |
Why?
| | Organ Size | 1 | 2012 | 14 | 0.110 |
Why?
| | Hospitals, Teaching | 1 | 2012 | 4 | 0.110 |
Why?
| | Polymyxins | 1 | 2012 | 2 | 0.100 |
Why?
| | Wound Infection | 1 | 2012 | 3 | 0.100 |
Why?
| | Ointments | 1 | 2012 | 4 | 0.100 |
Why?
| | Inguinal Canal | 2 | 2015 | 3 | 0.100 |
Why?
| | Administration, Topical | 1 | 2012 | 5 | 0.100 |
Why?
| | Education, Medical | 1 | 2012 | 3 | 0.100 |
Why?
| | Drug Costs | 1 | 2012 | 3 | 0.100 |
Why?
| | Hypoxia, Brain | 1 | 2012 | 1 | 0.100 |
Why?
| | Sex Distribution | 2 | 2012 | 17 | 0.100 |
Why?
| | Polytetrafluoroethylene | 1 | 2012 | 2 | 0.100 |
Why?
| | Uncertainty | 1 | 2012 | 10 | 0.100 |
Why?
| | Diarrhea | 1 | 2012 | 18 | 0.100 |
Why?
| | Ultrasonography, Prenatal | 1 | 2012 | 9 | 0.100 |
Why?
| | Voice Quality | 1 | 2011 | 1 | 0.100 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 3 | 0.100 |
Why?
| | Sternum | 1 | 2011 | 5 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 84 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2011 | 11 | 0.100 |
Why?
| | Methylprednisolone | 1 | 2011 | 2 | 0.100 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 2 | 0.100 |
Why?
| | Spinal Cord Injuries | 1 | 2011 | 3 | 0.100 |
Why?
| | Cerebral Palsy | 1 | 2012 | 18 | 0.100 |
Why?
| | Biomarkers | 1 | 2012 | 136 | 0.100 |
Why?
| | Blister | 1 | 2011 | 2 | 0.100 |
Why?
| | Oximetry | 1 | 2011 | 8 | 0.100 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 5 | 0.100 |
Why?
| | Catheter-Related Infections | 1 | 2011 | 22 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2011 | 17 | 0.100 |
Why?
| | Personnel Selection | 1 | 2011 | 3 | 0.100 |
Why?
| | Reference Values | 1 | 2011 | 39 | 0.100 |
Why?
| | Colonic Pouches | 1 | 2011 | 1 | 0.100 |
Why?
| | Hand Injuries | 1 | 2011 | 2 | 0.100 |
Why?
| | Bacteremia | 1 | 2011 | 25 | 0.100 |
Why?
| | Dermatofibrosarcoma | 1 | 2011 | 1 | 0.100 |
Why?
| | Angiography | 2 | 2024 | 8 | 0.100 |
Why?
| | Fibrin Tissue Adhesive | 2 | 2008 | 2 | 0.100 |
Why?
| | Bronchial Fistula | 2 | 2008 | 3 | 0.100 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.090 |
Why?
| | Skin Neoplasms | 1 | 2011 | 11 | 0.090 |
Why?
| | Bibliometrics | 1 | 2010 | 1 | 0.090 |
Why?
| | Journal Impact Factor | 1 | 2010 | 1 | 0.090 |
Why?
| | Cross-Cultural Comparison | 1 | 2010 | 2 | 0.090 |
Why?
| | Neoadjuvant Therapy | 1 | 2010 | 5 | 0.090 |
Why?
| | Research Support as Topic | 1 | 2010 | 6 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2010 | 5 | 0.090 |
Why?
| | Research | 1 | 2010 | 13 | 0.090 |
Why?
| | Patient Admission | 1 | 2010 | 9 | 0.090 |
Why?
| | Amoxicillin | 1 | 2010 | 4 | 0.090 |
Why?
| | History, 20th Century | 1 | 2010 | 6 | 0.090 |
Why?
| | Prosthesis Design | 1 | 2010 | 8 | 0.090 |
Why?
| | History, 21st Century | 1 | 2010 | 6 | 0.090 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.090 |
Why?
| | Coated Materials, Biocompatible | 2 | 2011 | 2 | 0.090 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.090 |
Why?
| | Intestinal Diseases | 1 | 2010 | 4 | 0.090 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 3 | 0.090 |
Why?
| | Mammaplasty | 1 | 2010 | 3 | 0.090 |
Why?
| | Dyspnea | 2 | 2020 | 4 | 0.090 |
Why?
| | Diphenhydramine | 1 | 2010 | 2 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2010 | 7 | 0.090 |
Why?
| | Attitude | 1 | 2010 | 10 | 0.090 |
Why?
| | Intestines | 1 | 2010 | 29 | 0.090 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 3 | 0.090 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2009 | 4 | 0.090 |
Why?
| | Hydrocephalus | 1 | 2009 | 8 | 0.090 |
Why?
| | Infarction | 1 | 2009 | 2 | 0.090 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 18 | 0.090 |
Why?
| | Professional Practice | 1 | 2009 | 4 | 0.080 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2021 | 7 | 0.080 |
Why?
| | Duodenostomy | 1 | 2009 | 1 | 0.080 |
Why?
| | Jejunostomy | 1 | 2009 | 2 | 0.080 |
Why?
| | Atrophy | 2 | 2022 | 6 | 0.080 |
Why?
| | Adrenocortical Adenoma | 1 | 2009 | 2 | 0.080 |
Why?
| | Injections, Intralesional | 1 | 2009 | 1 | 0.080 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2009 | 3 | 0.080 |
Why?
| | Hypertension, Renal | 1 | 2009 | 4 | 0.080 |
Why?
| | Peritoneal Cavity | 1 | 2008 | 3 | 0.080 |
Why?
| | Accidents | 1 | 2008 | 2 | 0.080 |
Why?
| | Biliary Tract Diseases | 1 | 2008 | 5 | 0.080 |
Why?
| | Fecal Impaction | 1 | 2008 | 3 | 0.080 |
Why?
| | Perfusion | 3 | 2003 | 8 | 0.080 |
Why?
| | Dehydration | 1 | 2008 | 2 | 0.080 |
Why?
| | Goals | 1 | 2008 | 6 | 0.080 |
Why?
| | Infant Food | 1 | 2008 | 6 | 0.080 |
Why?
| | Surgical Stapling | 1 | 2008 | 1 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2009 | 32 | 0.080 |
Why?
| | Failure to Thrive | 1 | 2008 | 7 | 0.080 |
Why?
| | Precancerous Conditions | 1 | 2008 | 6 | 0.080 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2008 | 5 | 0.080 |
Why?
| | Midwestern United States | 2 | 2019 | 34 | 0.080 |
Why?
| | Duodenoscopy | 1 | 2008 | 3 | 0.080 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2008 | 13 | 0.080 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 14 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2008 | 71 | 0.080 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.080 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.080 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.080 |
Why?
| | Observation | 1 | 2008 | 2 | 0.080 |
Why?
| | Disease Progression | 1 | 2008 | 111 | 0.080 |
Why?
| | Surgical Equipment | 1 | 2007 | 1 | 0.080 |
Why?
| | Down Syndrome | 1 | 2008 | 39 | 0.080 |
Why?
| | Wandering Spleen | 1 | 2007 | 1 | 0.070 |
Why?
| | Cysts | 1 | 2007 | 4 | 0.070 |
Why?
| | Silk | 1 | 2007 | 1 | 0.070 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.070 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2007 | 8 | 0.070 |
Why?
| | Urinary Tract | 1 | 2007 | 10 | 0.070 |
Why?
| | Mullerian Ducts | 1 | 2006 | 3 | 0.070 |
Why?
| | Uterus | 1 | 2006 | 10 | 0.070 |
Why?
| | In Vitro Techniques | 2 | 2003 | 23 | 0.070 |
Why?
| | Relative Value Scales | 1 | 2006 | 2 | 0.070 |
Why?
| | Respiration, Artificial | 2 | 2019 | 17 | 0.070 |
Why?
| | Urachus | 1 | 2005 | 3 | 0.070 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.070 |
Why?
| | Urinary Bladder | 1 | 2005 | 7 | 0.070 |
Why?
| | Cesarean Section | 1 | 2005 | 5 | 0.070 |
Why?
| | Hemolysis | 2 | 2002 | 4 | 0.070 |
Why?
| | Bandages, Hydrocolloid | 1 | 2005 | 1 | 0.060 |
Why?
| | Ischemia | 2 | 2002 | 7 | 0.060 |
Why?
| | Bilirubin | 2 | 2015 | 26 | 0.060 |
Why?
| | Hypospadias | 1 | 2005 | 4 | 0.060 |
Why?
| | Obesity, Morbid | 1 | 2005 | 9 | 0.060 |
Why?
| | Laryngoscopy | 2 | 2017 | 4 | 0.060 |
Why?
| | Dilatation, Pathologic | 1 | 2004 | 6 | 0.060 |
Why?
| | Mitomycin | 1 | 2003 | 1 | 0.060 |
Why?
| | Doxorubicin | 1 | 2003 | 15 | 0.060 |
Why?
| | Cisplatin | 1 | 2003 | 10 | 0.060 |
Why?
| | Food, Formulated | 1 | 2023 | 4 | 0.060 |
Why?
| | Allopurinol | 1 | 2003 | 1 | 0.060 |
Why?
| | Raffinose | 1 | 2003 | 1 | 0.060 |
Why?
| | Organ Preservation Solutions | 1 | 2003 | 1 | 0.060 |
Why?
| | Tissue and Organ Harvesting | 1 | 2003 | 2 | 0.060 |
Why?
| | Osteogenesis | 1 | 2003 | 6 | 0.060 |
Why?
| | Glutathione | 1 | 2003 | 11 | 0.060 |
Why?
| | Urea | 1 | 2003 | 12 | 0.060 |
Why?
| | Models, Animal | 1 | 2003 | 10 | 0.060 |
Why?
| | Adenosine | 1 | 2003 | 8 | 0.060 |
Why?
| | Homeostasis | 1 | 2003 | 8 | 0.060 |
Why?
| | Palliative Care | 2 | 2014 | 16 | 0.050 |
Why?
| | Insulin | 1 | 2003 | 50 | 0.050 |
Why?
| | Hemodilution | 1 | 2022 | 1 | 0.050 |
Why?
| | Frozen Sections | 1 | 2022 | 1 | 0.050 |
Why?
| | Interrupted Time Series Analysis | 1 | 2022 | 1 | 0.050 |
Why?
| | Bile | 1 | 2002 | 2 | 0.050 |
Why?
| | Patient Transfer | 1 | 2022 | 8 | 0.050 |
Why?
| | Morphine | 1 | 2022 | 11 | 0.050 |
Why?
| | Fatty Liver | 1 | 2002 | 4 | 0.050 |
Why?
| | Healthcare Disparities | 1 | 2022 | 22 | 0.050 |
Why?
| | Hepatocytes | 1 | 2002 | 8 | 0.050 |
Why?
| | Cold Temperature | 1 | 2002 | 3 | 0.050 |
Why?
| | Hemodynamics | 1 | 2002 | 10 | 0.050 |
Why?
| | Hot Temperature | 1 | 2002 | 6 | 0.050 |
Why?
| | Cryopreservation | 1 | 2002 | 5 | 0.050 |
Why?
| | Intensive Care Units | 1 | 2022 | 17 | 0.050 |
Why?
| | Photography | 1 | 2021 | 4 | 0.050 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2021 | 9 | 0.050 |
Why?
| | Outpatients | 1 | 2021 | 27 | 0.050 |
Why?
| | Ultrasonography, Mammary | 1 | 2021 | 1 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2001 | 9 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2021 | 2 | 0.050 |
Why?
| | Breast | 1 | 2021 | 4 | 0.050 |
Why?
| | Ribonuclease III | 1 | 2021 | 2 | 0.050 |
Why?
| | DEAD-box RNA Helicases | 1 | 2021 | 4 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2021 | 19 | 0.050 |
Why?
| | Insurance Benefits | 1 | 2020 | 1 | 0.050 |
Why?
| | BK Virus | 1 | 2021 | 3 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 5 | 0.050 |
Why?
| | Mucormycosis | 1 | 2021 | 4 | 0.050 |
Why?
| | Hospitals, University | 1 | 2020 | 3 | 0.050 |
Why?
| | Delphi Technique | 1 | 2020 | 11 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 99 | 0.050 |
Why?
| | Medicaid | 1 | 2020 | 38 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 1 | 0.040 |
Why?
| | Nausea | 1 | 2020 | 16 | 0.040 |
Why?
| | Plasma | 1 | 2020 | 7 | 0.040 |
Why?
| | Mutation | 1 | 2021 | 212 | 0.040 |
Why?
| | Parenteral Nutrition | 1 | 2019 | 7 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 14 | 0.040 |
Why?
| | Age of Onset | 2 | 2013 | 28 | 0.040 |
Why?
| | Shock | 1 | 2019 | 4 | 0.040 |
Why?
| | Prolapse | 1 | 2018 | 3 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 9 | 0.040 |
Why?
| | Preoperative Period | 1 | 2018 | 5 | 0.040 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2018 | 4 | 0.040 |
Why?
| | Puberty | 1 | 2018 | 7 | 0.040 |
Why?
| | Program Evaluation | 1 | 2018 | 45 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2018 | 21 | 0.040 |
Why?
| | Infant Care | 1 | 2017 | 3 | 0.040 |
Why?
| | Biliary Atresia | 1 | 2017 | 10 | 0.040 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2017 | 1 | 0.040 |
Why?
| | Tennessee | 1 | 2017 | 1 | 0.040 |
Why?
| | Parenteral Nutrition, Total | 1 | 2017 | 6 | 0.040 |
Why?
| | Tracheostomy | 1 | 2017 | 13 | 0.040 |
Why?
| | Vancomycin | 1 | 2017 | 17 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 38 | 0.040 |
Why?
| | Exercise | 1 | 2018 | 140 | 0.040 |
Why?
| | Peritonitis | 1 | 2017 | 58 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2016 | 5 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2016 | 24 | 0.040 |
Why?
| | Rare Diseases | 1 | 2017 | 48 | 0.030 |
Why?
| | Ligation | 1 | 2015 | 3 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2015 | 4 | 0.030 |
Why?
| | Reticulocyte Count | 1 | 2015 | 1 | 0.030 |
Why?
| | Reticulocytes | 1 | 2014 | 1 | 0.030 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2014 | 1 | 0.030 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2014 | 22 | 0.030 |
Why?
| | Regional Medical Programs | 1 | 2014 | 1 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 2 | 0.030 |
Why?
| | Anesthesia | 1 | 2014 | 3 | 0.030 |
Why?
| | Kansas | 1 | 2014 | 43 | 0.030 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.030 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.030 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.030 |
Why?
| | Incidental Findings | 1 | 2014 | 8 | 0.030 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 3 | 0.030 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 3 | 0.030 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 3 | 0.030 |
Why?
| | Respiratory Tract Diseases | 1 | 2014 | 7 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2014 | 64 | 0.030 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 2 | 0.030 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.030 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.030 |
Why?
| | Feces | 1 | 2013 | 37 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2012 | 12 | 0.030 |
Why?
| | Pleural Cavity | 1 | 2012 | 1 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2012 | 2 | 0.030 |
Why?
| | Expectorants | 1 | 2012 | 2 | 0.030 |
Why?
| | Enterostomy | 1 | 2012 | 2 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2012 | 4 | 0.030 |
Why?
| | Probiotics | 1 | 2012 | 10 | 0.030 |
Why?
| | Temperature | 2 | 2002 | 12 | 0.030 |
Why?
| | Tracheotomy | 1 | 2011 | 2 | 0.030 |
Why?
| | Disinfection | 1 | 2011 | 1 | 0.030 |
Why?
| | Bandages | 1 | 2011 | 2 | 0.020 |
Why?
| | Povidone-Iodine | 1 | 2011 | 3 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2011 | 14 | 0.020 |
Why?
| | Ethanol | 1 | 2011 | 7 | 0.020 |
Why?
| | Chlorhexidine | 1 | 2011 | 3 | 0.020 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 8 | 0.020 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.020 |
Why?
| | Lymphoma | 1 | 2011 | 9 | 0.020 |
Why?
| | Leukemia | 1 | 2011 | 15 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 18 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 30 | 0.020 |
Why?
| | Foundations | 1 | 2010 | 1 | 0.020 |
Why?
| | United States Public Health Service | 1 | 2010 | 1 | 0.020 |
Why?
| | Committee Membership | 1 | 2010 | 1 | 0.020 |
Why?
| | Electronic Mail | 1 | 2010 | 2 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2010 | 5 | 0.020 |
Why?
| | Financial Support | 1 | 2010 | 2 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 29 | 0.020 |
Why?
| | Gastrointestinal Motility | 1 | 2010 | 6 | 0.020 |
Why?
| | Nipples | 1 | 2010 | 3 | 0.020 |
Why?
| | Diatrizoate Meglumine | 1 | 2009 | 1 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 4 | 0.020 |
Why?
| | Omentum | 1 | 2009 | 3 | 0.020 |
Why?
| | Pneumoperitoneum | 1 | 2009 | 2 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2009 | 22 | 0.020 |
Why?
| | Hamartoma | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 16 | 0.020 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 6 | 0.020 |
Why?
| | Aspergillosis | 1 | 2007 | 1 | 0.020 |
Why?
| | Lung Diseases, Fungal | 1 | 2007 | 1 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 5 | 0.020 |
Why?
| | Emergencies | 1 | 2007 | 11 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2007 | 33 | 0.020 |
Why?
| | Peptostreptococcus | 1 | 2007 | 1 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 1 | 0.020 |
Why?
| | Pelvis | 1 | 2007 | 4 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 231 | 0.020 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 10 | 0.020 |
Why?
| | Neoplasms | 1 | 2008 | 128 | 0.020 |
Why?
| | Urination | 1 | 2005 | 2 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2005 | 19 | 0.020 |
Why?
| | Health Care Costs | 1 | 2005 | 33 | 0.020 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 5 | 0.020 |
Why?
| | Causality | 1 | 2003 | 10 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 31 | 0.010 |
Why?
| | Hypothermia, Induced | 1 | 2001 | 2 | 0.010 |
Why?
| | Liver Function Tests | 1 | 2001 | 4 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|